INS and diabetes mellitus: Moreover, GLP-1 agonists can be used in a standardised way compared to insulin and for all of these reasons the American Diabetes Association and European Association for the Study of Diabetes recommend using these pharmacological agents when oral antidiabetic agents alone fail (for example metformin), instead of insulin, despite the two classes having a similar efficacy in controlling blood glucose levels [26].